RPC-1063-MS-001: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod

April 07, 2021
https://clinicaltrials.gov/ct2/show/NCT04140305
Multiple Sclerosis
Principal Investigator: Anza B Memon, MD
Multiple Sclerosis, Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System
Accepting Participants
313-916-1482